{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-238450","form_type":"8-K","ticker":"SYBX","cik":"0001527599","company_name":"SYNLOGIC, INC.","filed_at":"2022-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.030595+00:00","generated_at":"2026-06-23T15:18:33.406676+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Synlogic achieves second research milestone under Roche IBD collaboration","bullets":["Second pre-specified milestone earned; milestone payment triggered under Roche collaboration.","First milestone was achieved and payment earned in September 2021.","Collaboration Agreement signed June 2021; Roche has exclusive option to negotiate a license after research period."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-238450","json":"https://secwatch.observer/filing/0001193125-22-238450.json","markdown":"https://secwatch.observer/filing/0001193125-22-238450.md","text":"https://secwatch.observer/filing/0001193125-22-238450.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527599/000119312522238450/0001193125-22-238450-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527599/000119312522238450/d373052d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T15:18:33.406676+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}